Jingjing Sun

Jingjing Sun has more than 10 years of experience developing nanoformulations for cancer therapy, including Duo Oncology's lead product. She is an inventor of 7 issued/pending patents in this field. She has also published one book chapter and 35 peer-reviewed papers in top journals. Dr. Sun is an aspiring Research Instructor in Department of Pharmaceutical Sciences, University of Pittsburgh where she also completed a post doc. She received her Ph.D. in Polymer Chemistry and Physics from the University of Chinese Academy of Sciences.